Lévy, S <br/><br/>
[Management of gliomas].  [electronic resource] 

 -  Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique  Oct 2014 
 - 461-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1769-6658 
<br/><br/><label>Standard No.: </label>10.1016/j.canrad.2014.07.147  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Age Factors<br/>Antibodies, Monoclonal, Humanized--adverse effects<br/>Antineoplastic Agents, Alkylating--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Bevacizumab<br/>Brain Neoplasms--genetics<br/>Chemoradiotherapy--adverse effects<br/>Chromosome Deletion<br/>Chromosomes, Human, Pair 1--genetics<br/>Clinical Trials as Topic<br/>Combined Modality Therapy<br/>Dacarbazine--analogs & derivatives<br/>Dose Fractionation, Radiation<br/>Drug Resistance, Neoplasm<br/>Glioma--genetics<br/>Humans<br/>Lomustine--administration & dosage<br/>Methylation<br/>Multicenter Studies as Topic<br/>Neoplasm Proteins--metabolism<br/>Neurosurgical Procedures<br/>O(6)-Methylguanine-DNA Methyltransferase--metabolism<br/>Procarbazine--administration & dosage<br/>Radiotherapy Dosage<br/>Radiotherapy, Intensity-Modulated--adverse effects<br/>Temozolomide<br/>Treatment Outcome<br/>Vincristine--administration & dosage